Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Published 22/05/2023, 13:06
Updated 22/05/2023, 14:10
© Reuters.  Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • SeqLL Inc. (NASDAQ: SQL) shares surged 61.1% to $0.54 in pre-market trading after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss.
  • CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) shares rose 45.3% to $2.31 in pre-market trading after gaining around 18% on Friday. CNS Pharmaceuticals posted a wider first-quarter loss.
  • Immix Biopharma, Inc. (NASDAQ: IMMX) shares gained 44.5% to $2.37 in pre-market trading after the company disclosed NXC-201 positive clinical results at The American Society of Gene and Cell Therapy.
  • Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) gained 37.4% to $12.24 in pre-market trading. Hepion Pharmaceuticals said it expects to release topline results from the Phase 2 ALTITUDE-NASH clinical trial before the market opens on May 22, 2023.
  • Netcapital Inc. (NASDAQ: NCPL) shares gained 31.1% to $2.57 in pre-market trading after gaining over 6% on Friday.
  • ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) rose 27.1% to $0.54 in pre-market trading after the company reported changes to ZyVersa’s board of directors.
  • Celularity Inc. (NASDAQ: CELU) shares climbed 21.6% to $0.79 in pre-market trading. Celularity highlighted presentation of Phase 1 data on MLASC therapy in patients with Crohn's Disease.
  • Forge Global Holdings, Inc. (NASDAQ: FRGE) shares rose 14.9% to $1.31 in pre-market trading after dropping over 12% on Friday.
  • Nanobiotix S.A. (NASDAQ: NBTX) gained 11.5% to $5.19 in pre-market trading. NANOBIOTIX recently issued an update on operational progress and reported financial results for the for the first quarter.
  • Toro Corp. (NASDAQ: TORO) rose 10.5% to $4.42 in pre-market trading as the company reported the the sale of the M/T Wonder Polaris and the M/T wonder bellatrix for an aggregate $71.5 million and aggregate expected net gain of $42.9 million.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Volcon, Inc. (NASDAQ: VLCN) fell 37.5% to $0.68 in pre-market as the company said it intends to offer its securities in a firm commitment underwritten public offering.
  • Daxor Corporation (NASDAQ: DXR) shares dropped 21.6% to $9.80 in pre-market trading after the company reported an underwritten public offering of shares of its common stock.
  • SunCar Technology Group Inc. (NASDAQ: SDA) fell 19.2% to $6.30 in pre-market trading after jumping 90% on Friday.
  • Mallinckrodt plc (NYSE: MNK) fell 17.3% to $5.21 in pre-market trading.
  • IZEA Worldwide, Inc. (NASDAQ: IZEA) shares fell 16.3% to $0.5702 in pre-market trading after dropping 10% on Friday. IZEA Worldwide recently posted a wider-than-expected quarterly loss.
  • Baudax Bio, Inc. (NASDAQ: BXRX) fell 12.2% to $0.56 in pre-market trading. Baudax Bio recently posted a first-quarter loss of $3.19 per share.
  • Zapp Electric Vehicles Group Limited (NASDAQ: ZAPP) fell 11.8% to $2.42 in pre-market trading after dropping 6% on Friday.
  • Flora Growth Corp. (NASDAQ: FLGC) fell 10.3% to $0.2332 in pre-market trading after surging 8% on Friday. Flora Growth recently posted a narrower-than-expected quarterly loss.
  • Biocept, Inc. (NASDAQ: BIOC) shares dropped 9.6% to $6.01 in pre-market trading. Biocept recently announced a 1-for-30 reverse stock split..
  • Medicenna Therapeutics Corp. (NASDAQ: MDNA) fell 8.4% to $0.57 in pre-market trading.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.